The Endocannabinoid System Explained

To understand why cannabis affects the body the way it does, you have to understand the endocannabinoid system — a signalling network humans (and most animals) carry naturally. Much of what we know about it was uncovered through Israeli research, which is part of why Israel looms so large in cannabis science. This guide explains it in plain terms.

This guide is informational and is not medical advice.

What it is

The endocannabinoid system (ECS) is a network of molecules and receptors that helps regulate a wide range of bodily functions — among them pain, mood, appetite, sleep, memory and immune response. It has three main parts: endocannabinoids (cannabinoid molecules the body makes itself), receptors that they bind to, and enzymes that build and break them down. Its broad job is balance — keeping the body's internal systems within a stable range.

The body's own cannabinoids

The system gets its name from cannabis only because cannabis was the route to discovering it. The first endocannabinoid, anandamide, was identified in 1992 by Raphael Mechoulam's group at the Hebrew University of Jerusalem (Wikipedia); a second major one, 2-AG, followed. These are compounds your body produces on demand to signal across this network. See our profile of Raphael Mechoulam for how that discovery happened.

The receptors

Endocannabinoids act mainly on two receptor types:

• CB1, concentrated in the brain and central nervous system, is heavily involved in the psychoactive and neurological effects associated with THC.
• CB2, found more in immune cells and peripheral tissue, is associated with inflammation and immune regulation.

How cannabis fits in

This is the key insight: the cannabinoids in the cannabis plant — THC, CBD and others — are shaped enough like the body's own endocannabinoids to interact with the same system. THC binds directly to CB1 receptors, producing its characteristic effects; CBD acts more indirectly, influencing the system without the same intoxication. In other words, cannabis works not by doing something foreign to the body, but by engaging a regulatory system that is already there.

Why it matters for medicine

Because the ECS touches so many functions, it is a plausible target for a striking range of conditions — which is exactly why Israeli research institutions study cannabinoids for everything from pain and epilepsy to inflammation and metabolic disease. It also explains why effects vary so much between individuals: people differ in their endocannabinoid biology. The therapeutic promise and the unpredictability come from the same source.

For the institutions advancing this science, see Israel's cannabis research institutions; for why whole-plant effects can differ from isolated compounds, see the entourage effect. More is collected in our Research hub.